Editorial Expression of Concern: Egypt Rheumatol Rehabil 48, 13 (2021)
https://doi.org/10.1186/s43166-021-00063-4
The Editors-in-Chief would like to alert readers that concerns have been raised regarding statistical discrepancies in the data reported in the article [1]. The authors have not been able to provide the original data for examination. Readers are advised to interpret these results with caution.
Hanan S. M. Abozaid, Tamer M. Soliman, Mohamed Ali Ismail, Esam M. Abualfadl and Ahmed Roshdi Hamed Ahmed agree to this editorial expression of concern. Hesham M. Hefny and Emad A. M. Youssef have not responded to any correspondence from the Publisher about this editorial expression of concern.
Reference
Hefny et al (2021) Urinary epidermal growth factor as a marker for lupus nephritis: clinical, laboratory, and histopathological study. Egypt Rheumatol Rehabil 48:13. https://doi.org/10.1186/s43166-021-00063-4
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hefny, H.M., Abualfadl, E.M., Youssef, E.A.M. et al. Editorial Expression of Concern: Urinary epidermal growth factor as a marker for lupus nephritis: clinical, laboratory, and histopathological study. Egypt Rheumatol Rehabil 51, 29 (2024). https://doi.org/10.1186/s43166-024-00262-9
Published:
DOI: https://doi.org/10.1186/s43166-024-00262-9